ammonium molybdate

Also found in: Encyclopedia, Wikipedia.

am·mo·ni·um mo·lyb·date

compound used in electron microscopy as a negative stain, and as a reagent for alkaloids and other substances.
References in periodicals archive ?
However, when the hardener is modified by the addition of ammonium molybdate, the retarding effects of the siloxane of the component on the curing reactions is reduced considerably.
However, the systems containing ammonium molybdate were not transparent, because the undissolved particles give rise to considerable haziness.
The addition of ammonium molybdate in the formulation brings about a further increase in the [T.
The further modification of the hardener mixture with the addition of ammonium molybdate leads to an even stronger pseudoplastic behavior, characterized by a very high viscosity at low shear rates.
4] (purchased from Sigma Aldrich) in reaction with ammonium molybdate and stannous chloride.
Tenders are invited for Supply of Chemical items and Scientific equipment to SHC, Ballari : Sulphuric acid (CP), Potassium Dichromate, Sucrose (AR), Sodium Bicarbonate, Ammonium Molybdate, Potassium Antimony Tartarate, Activated Charcoal, Potassium Dihydrogen Orthophosphate (AR), Potassium Chloride (AR), Ammonium Chloride, Ethyl Alcohol, MgCl2.
Plasma phosphorus is quantified through reaction with ammonium molybdate to form a colored phosphomolybdate complex (3).
The released inorganic phosphates were measured by a modified method of Heinonen and Lahti (1981) with a freshly prepared acetone ammonium molybdate (AAM) reagent consisting of acetone, 5N sulfuric acid, and 10 mM ammonium molybdate (2:1:1, v/v).
8 ml of color reagent (25 ml ammonium molybdate solution [10 gm ammonium molybdate.
No other lots of Ammonium Molybdate Injection, USP are subject to this recall.
Ammonium Molybdate Injection, USP, Lot # 9409, for patient care and should immediately quarantine any product for return.
As is standard practice, and as stated in the Ammonium Molybdate Injection, USP, Product Package Insert, "Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit"